BSE filing, NSE: INDIGOPNTS. Summary written from the filing by ALFA Finder's alert engine.
Indigo Paints Ltd: key numbers
- Share price
- ₹1,016.80
- Market cap
- ₹4,853 Cr
- Revenue (annual)
- ₹1,405 Cr
- Net profit (annual)
- ₹145.1 Cr
- P/E (TTM)
- 30.2×Sector 41.7×
- Promoter holding
- 53.81%-0.07% QoQ
- FII holding
- 5.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indigo Paints Ltd
All →Indigo Paints Board Meeting Date
Indigo Paints will hold a board meeting on October 30, 2026, to consider and approve standalone and consolidated financial results for the period ended September 30, 2026.
Indigo Paints Other Announcement
Indigo Paints filed the mandatory Regulation 74(5) compliance certificate for the quarter ended September 30, 2026, issued by its registrar.
Indigo Paints Annual General Meeting
Indigo Paints held its 26th Annual General Meeting on September 12, 2026. Shareholders adopted financial results, approved the final dividend, and ratified director appointments.
Indigo Paints Earnings Call Transcript: Key Takeaways
Indigo Paints reported strong double-digit growth in Q1 FY27, outperforming the paint sector with expanded EBITDA and PAT margins. Management highlighted successful operational leverage and distribution network depth.
Indigo Paints Business Update
Indigo Paints Limited submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26 in compliance with SEBI LODR regulations.
Indigo Paints Annual Report
Indigo Paints Ltd has submitted its Annual Report for the financial year 2025-26. The 26th Annual General Meeting is scheduled for September 12, 2026.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.